Tools and Strategies for Successful Deprescribing

Tools and Strategies for Successful Deprescribing Banner


Date & Location
Thursday, April 26, 2018, 8:00 AM - 5:00 PM, Hilton Short Pump Hotel, Richmond, VA

Overview

This program is designed for interprofessional providers involved in the prescribing and deprescribing process, including physicians, pharmacists, physician assistants, and nurse practitioners.  It aims to enhance provider knowledge and skill to facilitate successful deprescribing in practice. This workshop will utilize key pre-readings incorporated into continuing education credit as well as an equal division of both didactic and interactive sessions to engage participants.

For questions, please contact Shaun McCafferty at (804) 828-3640 or pharmacyce@vcu.edu

Registration Fees

Early Rate - $125
(ends 3/1/18)

Regular Rate - $150

VCU Alumni Rate - $100

Pharmacists, please be sure to enter your mm/dd birthday and NABP number when creating a profile and registering in this system.  Enter the NABP number in the "Board Number" field.  This is required for credit to be recorded in CPE Monitor following participation in this activity.

Session I: Overview of Deprescribing 9:00 - 9:45 
Kristin Zimmerman, PharmD, CGP, BCACP
Virginia Commonwealth University, School of Pharmacy

1. Describe the impact of polypharmacy and overdiagnosis on healthcare outcomes
2. Recognize interprofessional roles in the deprescribing process
3. Summarize key deprescribing trials and their outcomes

Session II: Potentially Inappropriate Medications 9:45 - 10:30 
Krista Larson Donohoe, Pharm.D., BCPS, CGP
Virginia Commonwealth University, School of Pharmacy

1. Apply tools to identify potentially inappropriate medications (PIMs)
2. Analyze a patient medication list to identify PIMs

Break: 10:30 - 10:45 

Session III: Prioritization 10:45 - 11:30 
Krista Larson Donohoe, Pharm.D., BCPS, CGP
Virginia Commonwealth University, School of Pharmacy

1. Analyze a patient medication list to prioritize medications for deprescribing
2. Elicit patient-specific information necessary to prioritize medications

Session IV: Implementation 11:30 - 12:30 
Kristin Zimmerman, PharmD, CGP, BCACP
Virginia Commonwealth University, School of Pharmacy

1. Utilize existing algorithms and decision-support tools when they exist
2. Construct a deprescribing plan for potentially inappropriate medications where explicit
guidance does not exist
3. Assess monitoring parameters to alter the deprescribing process when appropriate

Session V: Patient-Centered Approach 1:15 - 2:15pm

Amy M Linsky, MD, MSc.
VA Boston Healthcare System
Boston University School of Medicine

1. Identify patient-level barriers to deprescribing
2. Assess patient attitudes and experiences that predict medication discontinuation
3. Apply basic motivational interviewing (MI) techniques and strategies for patient
communication

Break: 2:15 - 2:30pm

Session VI: Successful Collaboration 2:30pm-3:30pm
Sarah E. Hobgood, MD
Virginia Commonwealth University, School of Medicine

Lana Sargent, Ph.D., RN, FNP-C, GNP-BC
Virginia Commonwealth University, School of Nursing

1. Utilize communication techniques to engage with interprofessional team members in the
deprescribing process
2. Identify care-coordination strategies to enhance successful deprescribing
3. Apply techniques to address system and patient-level barriers to deprescribing

This activity is a pre-conference symposium for the Virginia Geriatric Society's Annual meeting April 27- April 29. For more information, visit: http://www.vgsconference.org



Objectives
  1. Discuss the impact of polypharmacy and overdiagnosis on healthcare outcomes
  2. Recognize interprofessional roles in the deprescribing process
  3. Summarize key deprescribing trials and their outcomes
  4. Apply tools to identify potentially inappropriate medications (PIMs)
  5. Analyze a patient medication list to identify PIMs
  6. Analyze a patient medication list to prioritize medications for deprescribing
  7. Elicit patient-specific information necessary to prioritize medications
  8. Utilize existing algorithms and decision-support tools when they exist
  9. Construct a deprescribing plan for potentially inappropriate medications where explicit guidance does not exist
  10. Assess monitoring parameters to alter the deprescribing process when appropriate
  11. Identify patient-level barriers to deprescribing
  12. Assess patient attitudes and experiences that predict medication discontinuation
  13. Apply basic motivational interviewing techniques and strategies for patient communication
  14. Utilize communication techniques to engage with interprofessional team members in the deprescribing process
  15. Identify care-coordination strategies to enhance successful deprescribing
  16. Apply techniques to address system and patient-level barriers to deprescribing
  17. Discuss ethical and medical-cultural barriers for the deprescribing process
  18. Reflect on personal barriers to the deprescribing process
  19. Develop strategies to overcome these barriers

Registration
Questions?
Contact Shaun McCafferty - (804) 828-3640 or pharmacyce@vcu.edu.

Accreditation

VCU Health Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  VCU Health Continuing Medical Education designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits(TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

VCU School of Pharmacy Office of Continuing Education program is accredited by the Accreditation Council for Pharmacy Education, This home study and live course provides 5.5 contact hours (0.55 CEUs).  Participants must complete the home study, attend the entire live course, and complete evaluation in order to receive credit.  

UAN:  0294-0000-18-039-B01-P


Pharmacists:  Please be sure to enter your mm/dd birthday and NABP number when creating a profile in this system.  Enter the NABP number in the "Board Number" field.  This is required for credit to be recorded in CPE Monitor following participation in this activity.